Explore 3 Stock Ideas & Industry Insights Download Free Report

Gabelli Healthcare & WellnessRx Trust

Financial Services US GRX

9.08USD
0.11(1.23%)

Last update at 2026-06-23T20:00:00Z

Day Range

8.989.20
LowHigh

52 Week Range

8.469.87
LowHigh

Fundamentals

  • Previous Close 8.97
  • Market Cap138.62M
  • Volume54793
  • P/E Ratio61.40
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM0.15

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 2.29M -0.28500M 0.42M -47.44249M 42.74M
Minority interest - - - - -
Net income 2.29M -0.28500M 0.42M -47.44249M 42.74M
Selling general administrative 0.48M 0.42M 0.54M 0.73M 0.75M
Selling and marketing expenses - - - - -
Gross profit 12.79M 0.34M 1.24M -46.71459M 43.49M
Reconciled depreciation - - - - -
Ebit - - 3.04M - -
Ebitda 4.77M 2.68M 3.20M -44.26470M 42.74M
Depreciation and amortization - - 0.17M - -
Non operating income net other - - - - -
Operating income 4.74M 2.68M 3.20M -44.26470M 42.74M
Other operating expenses 10.53M 3.54M 3.59M 0.73M 0.75M
Interest expense 2.47M 2.92M 2.77M 3.18M 1.94M
Tax provision - - - - -
Interest income 0.84M 0.38M 0.64M 0.46M 44.95M
Net interest income -1.60642M -2.53560M -2.13782M -2.71561M -1.93106M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - -0.16789M - -
Total revenue 15.28M 3.26M 4.01M -46.71459M 43.49M
Total operating expenses 8.05M 0.63M 0.82M 0.73M 0.75M
Cost of revenue 2.48M 2.92M 2.77M - 5.00M
Total other income expense net -2.44664M -2.96811M -2.78143M -3.17779M -1.93779M
Discontinued operations - - - - -
Net income from continuing ops 2.29M -0.28500M 0.42M -47.44249M 42.74M
Net income applicable to common shares - - - - 42.74M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 241.89M 225.71M 239.04M 248.70M 350.84M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - 0.00708M 0.00647M - -
Total liab 83.38M 54.85M 54.23M 44.04M 86.88M
Total stockholder equity 158.51M 170.86M 184.81M 204.65M 263.95M
Deferred long term liab - - - - -
Other current liab 0.48M -0.01010M -0.00038M -3.52759M -6.22959M
Common stock 105.49M 110.02M 114.34M 125.10M 126.82M
Capital stock 105.49M 110.02M 114.34M 125.10M 126.82M
Retained earnings 53.02M 60.85M 70.47M 79.55M 137.13M
Other liab - - - - -
Good will - - - - -
Other assets - 225.71M 239.04M 0.16M 0.15M
Cash 0.02M - 0.00237M 0.05M -
Cash and equivalents - - - - -
Total current liabilities 12.52M 0.18M 0.00038M 3.53M 6.23M
Current deferred revenue - - -0.03146M - -
Net debt 70.70M 0.01M 53.32M -0.05049M 0.07M
Short term debt - 0.01M 0.00038M - 0.07M
Short long term debt - - - - -
Short long term debt total 70.72M 0.01M 53.32M - 0.07M
Other stockholder equity - - - - -
Property plant equipment - - - - -
Total current assets 0.41M 0.43M 0.78M 6.68M 0.48M
Long term investments 241.15M 224.96M 238.11M 241.86M 350.22M
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 0.39M 0.42M 0.77M 6.63M 0.48M
Long term debt - - - - 80.00M
Inventory - - - - -
Accounts payable 12.04M 0.18M 0.03M 3.53M 6.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.33M 0.32M 0.16M -241.86031M -350.21504M
Deferred long term asset charges - - - - -
Non current assets total 241.48M 225.28M 238.26M 241.86M 350.22M
Capital lease obligations - - - - -
Long term debt total - - - - 80.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities 67.63M 18.34M -0.06796M - -
Net borrowings -0.01010M 0.01M - - -
Total cash from financing activities 2.11M -13.11262M -6.65543M -58.06421M 18.93M
Change to operating activities - - - - -
Net income 2.29M -0.28500M 0.42M -47.44249M 42.74M
Change in cash 0.02M -0.00237M -0.04812M 0.05M -0.01179M
Begin period cash flow 0.00000M 0.00198M 0.05M 0.00000M 0.01M
End period cash flow 0.02M 0.00000M 0.00237M 0.05M 0.00000M
Total cash from operating activities 9.43M -2.32578M -0.35648M 58.11M -18.94399M
Issuance of capital stock 16.69M 10.35M 13.32M - 40.00M
Depreciation - - - - -
Other cashflows from investing activities - - 0.00000M - -
Dividends paid 10.15M 9.37M 9.94M -16.46730M -16.51916M
Change to inventory - - - - -
Change to account receivables 0.03M 0.35M 5.85M - -
Sale purchase of stock -4.36622M -4.46957M -9.93899M -41.59691M -4.41174M
Other cashflows from financing activities -0.02021M 0.71M 13.22M - 39.86M
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 11.80M 0.25M 2.43M -2.79754M 7.23M
Stock based compensation - - - - -
Other non cash items -4.66042M -2.28844M -3.21029M 108.35M -68.91166M
Free cash flow 9.43M 13.11M -0.35648M 58.11M -18.94399M

Peer Comparison

Sector: Financial Services Industry: Asset Management

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
GRX
Gabelli Healthcare & WellnessRx Trust
0.11 1.23% 9.08 61.40 - 47.48 0.86 45.85
BLK
BlackRock Inc
-36.41 3.46% 1015.33 26.25 19.57 6.33 2.90 6.35 17.13
BX
Blackstone Group Inc
-3.19 2.59% 120.07 33.20 20.12 11.05 11.56 9.14 15.74
BN
Brookfield Corp
-0.19 0.43% 43.94 94.78 11.89 1.35 2.37 4.58 10.79
IVSXF
Investor AB (publ)
- -% 39.80 20.83 - 0.88 1.11 10.01 1.68

Reports Covered

Stock Research & News

Profile

The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

Gabelli Healthcare & WellnessRx Trust

One Corporate Center, Rye, NY, United States, 10580-1422

Key Executives

Name Title Year Born
Mr. Wayne Christopher Pinsent C.F.A. Assistant VP and Ombudsman 1986
Mr. Mario Joseph Gabelli C.F.A., CFA Portfolio Mang. 1943
Mr. Bruce N. Alpert CPA, CPA Exec. VP & Chief Operating Officer 1952
Mr. Adam E. Tokar VP 1980
Mr. Carter W. Austin Sr. VP 1966
Mr. David I. Schachter VP 1953
Mr. Kevin V. Dreyer Portfolio Mang. NA
Mr. Jeffrey J. Jonas Jr., C.F.A., Jr. Portfolio Mang. NA
Mr. Wayne Christopher Pinsent C.F.A. Assistant Vice President and Ombudsman 1986
Mr. Mario Joseph Gabelli C.F.A. Portfolio Manager 1942

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions